Paraoxonase-1 (PON1) is an extracellular esterase contributing to the anti-atherogenic and
anti-inflammatory properties of HDL and has a protective role in the progression of …

Abstract Human serum paraoxonase 1 (PON1) is an enzyme with esterase activity, and is
physically bound to high-density lipoproteins (HDL). It plays a key role in the action of HDL …

Objectives The present study aims to evaluate the levels of HDL and Paraoxonase-1 (PON1)
and their correlation in atherosclerotic patients with and without diabetic mellitus (DM) as …

BACKGROUND: Paraoxonase-1 (PON1) is an esterase associated with the high-density
lipoprotein (HDL) in serum. To date, there have been few reports about circulating PON1 …

Introduction: Type 2 diabetes mellitus (DM) is a disease of metabolic dysregulation. The
current study was undertaken to understand the relationship between the fasting lipid profile …

Background: Human serum paraoxonase1 (PON1) an antioxidant enzyme closely
associated with high density lipoprotein (HDL) has been implicated in the prevention of low …

Abstract Background Paraoxonase-1 (PON-1) is an enzyme synthesized in the liver that has
antioxidant functions as it binds to the HDL particles and prevents the oxidation of LDL …

Background A longitudinal study assessed serum paraoxonase 1 (PON1) activity and
concentration as affected by age and as associated with the development of type 2 diabetes …

Recent studies implied that low-density lipoprotein (LDL) modified predominantly by
oxidation or glycation, significantly contributes to the formation of atherosclerotic lesions. In …

BACKGROUND: Serum paraoxonase-1 (PON-1) activity is decreased in clinical conditions
associated with low high-density lipoprotein cholesterol (HDL-C), increased lipid …